HOPE Foundation and Taiwan's Top Lung Cancer Experts Call for Seamless Integration of Early Screening, Precision Diagnostics, and Early Treatment
Taiwan's proactive approach to lung cancer prevention is recognized globally for its vision and effectiveness. In July 2022, the government launched the Lung Cancer Early Detection Program, offering biannual low-dose CT (LDCT) screenings for high-risk groups, including those with a family history of lung cancer and heavy smokers. This pioneering initiative has positioned Taiwan as an international role model in lung cancer prevention. Over the past three years, more than 210,000 screenings have led to the identification of 2,506 lung cancer cases—over 80% of which were diagnosed at an early stage, with late-stage diagnoses dropping sevenfold. Previously, late-stage diagnosis was the norm, but Taiwan's proactive policies have transformed the landscape, reversing the trend and ensuring that most initial lung cancer cases are now detected early.
During his recent visit to Taiwan, Dr. Cary Adams, CEO of the Union for International Cancer Control (UICC), commended Taiwan's National Cancer Control Program, its comprehensive cancer registry, and robust National Health Insurance (NHI) system for establishing an exemplary cancer care network. He encouraged Taiwan to further improve early lung cancer screening rates and timely access to treatment, reinforcing its status as a global public health leader. At the conference, Minister of Health and Welfare Dr. Chiu Tai-Yuan pledged ongoing cross-ministerial collaboration and policy innovation to improve early lung cancer detection and treatment. Legislator Wang Cheng-Hsu also reaffirmed his commitment to early detection and intervention, advocating for increased resources and improved legislation to ensure early-stage lung cancer patients receive comprehensive care.
Leading medical experts further emphasized Taiwan's advancements. Dr. Yang, Pan-Chyr, Academician of Academia Sinica, highlighted how the LDCT screening program has driven a shift toward earlier-stage diagnosis, with research indicating it could reduce lung cancer mortality by 53%. Dr. Chen Chien-Jen, Academician of Academia Sinica emphasized that the next key challenge is ensuring early-stage patients benefit from precision diagnostics and early treatment. Dr. Yang Cheng-Ta, President of the Taiwan Lung Cancer Society, added that emerging AI technology is now capable of analyzing LDCT images to predict an individual's six-year cancer risk, which will improve identification of high-risk groups and support early intervention. Dr. Yang Chih-Hsin, President of Taiwan Association for the Study of Lung Cancer, urged early-stage patients to undergo genetic testing promptly, enabling medical teams to tailor optimal treatment plans, including surgery, targeted therapy, or immunotherapy as adjuvant treatments.
HOPE called for NHI resources to shift toward early lung cancer diagnosis and treatment, highlighting the importance of genetic testing and adjuvant therapy for high-risk early-stage patients to reduce relapse and mortality. Clinical evidence shows that adjuvant targeted therapy after surgery for stage IB–IIIA lung cancer with EGFR mutations can reduce five-year mortality by 10%, which is vital for improving outcomes and easing the burden on the healthcare system. Dr. Chen Jin-Shing, Head of Thoracic Surgery Division at National Taiwan University Hospital, advocated for priority reimbursement of adjuvant targeted therapy for patients with stage IB-IIIA lung cancer, while Dr. Chen Chih-Yi, Board Member of HOPEemphasized the importance of improving access to early genetic testing and treatment. Dr. Huang, Ming-Shyan, President of the Taiwan Clinical Oncology Society, pointed out that early-stage lung cancer treatment in Taiwan is not yet fully aligned with international guidelines, and urged that expanded screening must be matched with optimized NHI resource allocation and improved treatment access.
Other leading voices reinforced the need for comprehensive care. Dr. Wang Chin-Chou, Board Member of Taiwan Society of Pulmonary and Critical Care Medicine, stressed that while surgery is the primary treatment for early-stage lung cancer, it must be accompanied by proactive adjuvant therapy strategies and long-term follow-up. Dr. Chang Wen-Cheng, CEO of Taiwan Cancer Foundation emphasized that the integration of screening, diagnosis, and treatment is crucial to truly realize early detection and treatment, as well as maximizing the value of screening program. Dr. Chen Jen-Shi, President of Taiwan Oncology Society, recommended that in addition to current NHI and Cancer Drug Fund financing, the government should promote diverse payment mechanisms—such as co-payment models or commercial insurance to supplement the NHI system—to further improve access to early lung cancer treatment.
Uniting multiple lung cancer treatment experts from medical centers across Taiwan, a concerted effort to usher in a new era of early lung cancer screening and treatment. (Listed by institution from North to South)
· Dr. Chen Yu-Min, Director of General Chest Medicine Department, Taipei Veterans General Hospital
· Dr. Lee Kang-Yun, Attending Physician, Division of Pulmonary Medicine, Shuang Ho Hospital
· Dr. Huang Chun-Yao, Attending Physician, Division of Chest Medicine, Taipei Tzu Chi Hospital
· Dr. Tsai Chen-Liang, Director of Pulmonary and Critical Care Medicine Division, Tri-Service General Hospital
· Dr. Yeh Yu-Wen, Physician, Division of Thoracic Medicine, Shin Kong Wu Ho-Su Memorial Hospital
· Dr. Chang Sheng-Yu, Attending Physician and Leader of the Lung Cancer Team, Far Eastern Memorial Hospital
· Dr. Yang Tsung-Ying, Director of General Chest Medicine Department, Taichung Veterans General Hospital
· Dr. Hsia Te-Chun, Deputy Director, Department of Internal Medicine, China Medical University Hospital
· Dr. Lin Chien-Chung, Attending Physician, Division of Chest Medicine, National Cheng Kung University Hospital
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
21 hours ago
- The Sun
HOPE Foundation and Taiwan's Top Lung Cancer Experts Call for Seamless Integration of Early Screening, Precision Diagnostics, and Early Treatment
TAIPEI, TAIWAN - Media OutReach Newswire - 16 August 2025 - Lung cancer continues to be the leading cause of cancer-related deaths worldwide. Yet, progress is within reach. In Taiwan, thanks to the National Lung Cancer Early Detection Program, the proportion of early-stage lung cancer cases continues to rise. Against this backdrop, HOPE Foundation for Cancer Care, one of the largest cancer-focused patient advocacy groups in Taiwan, recently hosted a press conference titled 'Healthy Taiwan, Leading the World – Ushering in a New Era of Early Screening and treatment of Lung Cancer'. The event brought together distinguished government officials, ten leading medical authorities in lung cancer, and renowned lung cancer experts from major medical centers nationwide to chart the next phase of early lung cancer prevention and control policies. United in their commitment, participants advocated for the seamless integration of early screening, precision diagnostics, and early treatment in lung cancer care, strengthening efforts to promote early detection and intervention. Ultimately, aiming to support Taiwan in achieving its ambitious goal of reducing cancer mortality rates by one-third by 2030, setting a new international benchmark in cancer control. Taiwan's proactive approach to lung cancer prevention is recognized globally for its vision and effectiveness. In July 2022, the government launched the Lung Cancer Early Detection Program, offering biannual low-dose CT (LDCT) screenings for high-risk groups, including those with a family history of lung cancer and heavy smokers. This pioneering initiative has positioned Taiwan as an international role model in lung cancer prevention. Over the past three years, more than 210,000 screenings have led to the identification of 2,506 lung cancer cases—over 80% of which were diagnosed at an early stage, with late-stage diagnoses dropping sevenfold. Previously, late-stage diagnosis was the norm, but Taiwan's proactive policies have transformed the landscape, reversing the trend and ensuring that most initial lung cancer cases are now detected early. During his recent visit to Taiwan, Dr. Cary Adams, CEO of the Union for International Cancer Control (UICC), commended Taiwan's National Cancer Control Program, its comprehensive cancer registry, and robust National Health Insurance (NHI) system for establishing an exemplary cancer care network. He encouraged Taiwan to further improve early lung cancer screening rates and timely access to treatment, reinforcing its status as a global public health leader. At the conference, Minister of Health and Welfare Dr. Chiu Tai-Yuan pledged ongoing cross-ministerial collaboration and policy innovation to improve early lung cancer detection and treatment. Legislator Wang Cheng-Hsu also reaffirmed his commitment to early detection and intervention, advocating for increased resources and improved legislation to ensure early-stage lung cancer patients receive comprehensive care. Leading medical experts further emphasized Taiwan's advancements. Dr. Yang, Pan-Chyr, Academician of Academia Sinica, highlighted how the LDCT screening program has driven a shift toward earlier-stage diagnosis, with research indicating it could reduce lung cancer mortality by 53%. Dr. Chen Chien-Jen, Academician of Academia Sinica emphasized that the next key challenge is ensuring early-stage patients benefit from precision diagnostics and early treatment. Dr. Yang Cheng-Ta, President of the Taiwan Lung Cancer Society, added that emerging AI technology is now capable of analyzing LDCT images to predict an individual's six-year cancer risk, which will improve identification of high-risk groups and support early intervention. Dr. Yang Chih-Hsin, President of Taiwan Association for the Study of Lung Cancer, urged early-stage patients to undergo genetic testing promptly, enabling medical teams to tailor optimal treatment plans, including surgery, targeted therapy, or immunotherapy as adjuvant treatments. HOPE called for NHI resources to shift toward early lung cancer diagnosis and treatment, highlighting the importance of genetic testing and adjuvant therapy for high-risk early-stage patients to reduce relapse and mortality. Clinical evidence shows that adjuvant targeted therapy after surgery for stage IB–IIIA lung cancer with EGFR mutations can reduce five-year mortality by 10%, which is vital for improving outcomes and easing the burden on the healthcare system. Dr. Chen Jin-Shing, Head of Thoracic Surgery Division at National Taiwan University Hospital, advocated for priority reimbursement of adjuvant targeted therapy for patients with stage IB-IIIA lung cancer, while Dr. Chen Chih-Yi, Board Member of HOPEemphasized the importance of improving access to early genetic testing and treatment. Dr. Huang, Ming-Shyan, President of the Taiwan Clinical Oncology Society, pointed out that early-stage lung cancer treatment in Taiwan is not yet fully aligned with international guidelines, and urged that expanded screening must be matched with optimized NHI resource allocation and improved treatment access. Other leading voices reinforced the need for comprehensive care. Dr. Wang Chin-Chou, Board Member of Taiwan Society of Pulmonary and Critical Care Medicine, stressed that while surgery is the primary treatment for early-stage lung cancer, it must be accompanied by proactive adjuvant therapy strategies and long-term follow-up. Dr. Chang Wen-Cheng, CEO of Taiwan Cancer Foundation emphasized that the integration of screening, diagnosis, and treatment is crucial to truly realize early detection and treatment, as well as maximizing the value of screening program. Dr. Chen Jen-Shi, President of Taiwan Oncology Society, recommended that in addition to current NHI and Cancer Drug Fund financing, the government should promote diverse payment mechanisms—such as co-payment models or commercial insurance to supplement the NHI system—to further improve access to early lung cancer treatment. Uniting multiple lung cancer treatment experts from medical centers across Taiwan, a concerted effort to usher in a new era of early lung cancer screening and treatment. (Listed by institution from North to South) · Dr. Chen Yu-Min, Director of General Chest Medicine Department, Taipei Veterans General Hospital · Dr. Lee Kang-Yun, Attending Physician, Division of Pulmonary Medicine, Shuang Ho Hospital · Dr. Huang Chun-Yao, Attending Physician, Division of Chest Medicine, Taipei Tzu Chi Hospital · Dr. Tsai Chen-Liang, Director of Pulmonary and Critical Care Medicine Division, Tri-Service General Hospital · Dr. Yeh Yu-Wen, Physician, Division of Thoracic Medicine, Shin Kong Wu Ho-Su Memorial Hospital · Dr. Chang Sheng-Yu, Attending Physician and Leader of the Lung Cancer Team, Far Eastern Memorial Hospital · Dr. Yang Tsung-Ying, Director of General Chest Medicine Department, Taichung Veterans General Hospital · Dr. Hsia Te-Chun, Deputy Director, Department of Internal Medicine, China Medical University Hospital · Dr. Lin Chien-Chung, Attending Physician, Division of Chest Medicine, National Cheng Kung University Hospital
The Sun
3 days ago
- The Sun
eefit Returns to the International Academic Stage — Patented Far Infrared Technology Praised by Nobel Laureate and Renowned Scientists
HONG KONG SAR - Media OutReach Newswire - 12 August 2025 - With a rapidly increasing aging population, chronic non-communicable diseases and sub-health problems faced by middle-aged and elderly people have become even more prominent. Modern medicine has standardised our current diagnosis and treatment system, especially in the intervention of acute symptoms and pathological control. However, in the face of health needs such as long-term management of chronic diseases and conditioning of sub-health problems, which require a 'holistic view' and 'continuous repair', its limitations in areas such as healthcare, functional restoration, and improvement of quality of life are gradually becoming apparent. In the context of improving the lifestyle and functional regulation of middle-aged and elderly people, we seek to help improve their health in a gentle and sustainable manner by exploring new health protection paths outside of traditional medicine. ' The 9th Young Scholars Conference on Ion Channels and Receptors & Forum on Biophysics and Innovative Drug Discovery ' was held in June 2025. As a leading energy healthcare technology company, 'eefit' became the focus of the event, revealing to the world the innovative application of their patented far infrared technology in healthcare, with results verified by internationally renowned academics and authorities. The benefit provides systematic health management solutions for the middle-aged and elderly population through non-invasive and non-drug methods, creating a new chapter in health technology. Recognized by Nobel Laureate and Renowned Scientists, eefit Far Infrared Technology is Acclaimed by International Authorities Organized by the Macau University of Science and Technology (M.U.S.T.), this forum brought together experts in various disciplines from around the world, including neuroscientists and biophysicists. In attendance was 1 991 Nobel Laureate in Physiology or Medicine Dr. Erwin Neher, who attended the event as the keynote speaker. It's worth noting that eefit has been collaborating closely with 'Dr. Neher's Biophysics Laboratory for Innovative Drug Discovery' since 2021, promoting transformative scientific research in far infrared technology. On a similar note, Prof. Vincent Wong of M.U.S.T. (among the top 2% of scientists in the world) introduced the significant effects of eefit's patented far infrared technology in improving intestinal microecology, regulating cell immunity, and alleviating symptoms of rheumatoid arthritis. His team's latest research has confirmed that this technology not only can enhance cerebral blood flow and reduce brain damage in patients with ischemic stroke but can also provide an innovative solution for rehabilitation treatment. Far Infrared Technology is Changing Our Lives eefit Has Constructed an All-encompassing 'Prevention + Maintenance + Restoration' Health Management System The middle-aged and elderly population is plagued by health issues, such as chronic pain, sleep disorders, immune system disorders, and Alzheimer's disease. eefit provides comprehensive solutions to address these issues through developing innovative healthcare products. At the forum, experts gathered at the booth set up by eefit to experience firsthand how technology redefines the health management of the elderly. Case 1: Disease prevention – protecting brain health at the source eefit's patented technology reduces the risk of Alzheimer's disease by reducing Aβ deposits and abnormal tau proteins. The latest research paper presented on-site showed that eefit far infrared energy can penetrate the blood-brain barrier, intervene in pathological protein aggregation, and build a strong line of defense for brain health. Case 2: Brain healthcare – improving stroke sequelae and neurological function For patients suffering from sequelae of stroke, eefit Luminous Energy Helmet and Meridian Pro Illuminator can promote microcirculation in the head and improve cerebral blood flow. The research conducted by the research team of Prof. Vincent Wong has confirmed that this technology can reduce stroke sequelae symptoms and dizziness. An expert user at the forum excitedly shared his feedback, 'I am a loyal fan of eefit products. I wear the Luminous Energy Helmet for 20 minutes daily. After one month, I find my memory improved, and I don't get dizzy as often.' Case 3: Chronic pain management – quick relief for joint and muscle pain In the field of pain management, products like EEFit Lite can accurately irradiate pain points and inhibit the release of inflammatory factors. Experts verified that '10 minutes of irradiation can reduce knee pain on a pain scale from 6 to 3, with effects lasting for more than 2 hours'. Case 4: Sleep quality – natural relief for nervous system eefit far infrared technology can relieve insomnia by regulating nervous system functions. eefit data shows that after daily use for 2 weeks, over 80% of users experienced a 50% reduction in the time they took to fall asleep, as well as an increased duration of deep sleep. Case 5: Digestive system repair – two-way regulation of intestinal microecology eefit far infrared energy achieves two-way regulation of gut microbiota in an innovative manner by inhibiting the excessive proliferation of pathogens while promoting the growth of beneficial bacteria and regulating the imbalance of intestinal microecology. Experimental data shows that after two weeks of intervention, the alpha diversity of gut microbiota (Chao1 index) increased by 30%, and abdominal bloating decreased by 45%. Nobel Laureate Dr. Neher and Prof. Vincent Wong expressed that the eefit technology system demonstrates innovation and practicality at the international forefront, establishing a new model for the health management of the elderly. Integrating Industry, Academia and Research: Innovative Paths Leading Industry Development eefit first introduced far infrared technology into health management through independent technology R&D and commercialization execution, which then attracted collaboration with reputable scientific research institutions. This closed-loop ecosystem of 'Demand-Driven Innovation' demonstrates benefit's ability to focus on the core benefits of products by starting from users' pain points then feeding back technological improvements into scientific research. At the forum banquet, eefit's Founder and Chairman Prof. Nick Wang remarked, 'We are honoured, looking back on our eight-year partnership between eefit and the research laboratory. This period of collaboration with deep integration of industry, academia and research has not only pioneered groundbreaking research but also produced fruitful scientific and technological achievements.' He emphasized that eefit has always been 'user demand-oriented' at its core, by first verifying the value of technology through market research and then extending the application boundaries with the help of prominent scientific researchers to achieve a seamless connection 'from lab to real life'. The Future is Here: eefit's Multi-dimensional Layout is Leading a New Era of Far Infrared Healthcare Technology eefit's future development focuses on three strategic directions: In terms of scaling technological capabilities, they will continue to increase their investment on R&D and explore new boundaries of far infrared technology applications in more areas that impact human health; In terms of advancing global collaboration, they will strengthen partnerships with notable international scientific research institutions and accelerate the process of global adoption; In the field of inclusive health accessibility, they will popularize home healthcare solutions through verified consumer-level healthcare products such as EEFit Lite, Chi Vitaliser, and Luminous Energy Helmet; and they will continue to pioneer the extension of far infrared technology in the field of health supplements, building an all-encompassing health management system of 'External healthcare devices + Internal balancing nutrition'. As a leading energy healthcare technology company in Hong Kong, eefit's all-encompassing health management system has been universally recognized by respected international scientists. Leveraging their pioneering edge in commercialisation and the ability to transform based on scientific research, eefit will continue to spearhead global innovation of far infrared healthcare technology, ensuring the benefits of science-backed wellness reach everyone.
The Sun
09-08-2025
- The Sun
Neo Smiles Dental Studio Marks 10 Years of Orthodontic Care in Singapore
SINGAPORE - Media OutReach Newswire - 8 August 2025 – Neo Smiles Dental Studio marks its 10th anniversary, reflecting on a decade of growth from a one-chair practice in the heartlands to a multi-branch provider of specialist orthodontic care. With clinics operating in Bedok, Serangoon, and Bishan, the practice group continues to serve students, working adults, and families through flexible appointment hours and structured treatment options designed for community accessibility. From Start-Up to Multi-Branch Practice Neo Smiles began as a solo practice focused on delivering affordable orthodontic care to residents in the heartlands. Over time, the clinic expanded its team and facilities to meet growing demand. Today, the clinic operates as a specialist orthodontic clinic chain in Singapore with three locations, offering a full suite of orthodontic care. The team includes three orthodontists, one oral surgeon, and several general dentists. Services range from traditional metal and ceramic braces to Damon self-ligating systems and aligner treatments such as Invisalign, as well as oral surgery procedures, including wisdom tooth removal with sedation, and routine dental care. Neo Smiles has also been awarded the Invisalign Diamond Tier Practice, supported by in-clinic technology, dedicated orthodontic staff, and the use of iTero Lumina 3D intraoral scanners. Clinics are designed with patient comfort in mind, featuring amenities such as piped-in music, aromatherapy, and overhead televisions to create a more relaxed treatment environment. 'When we started Neo Smiles, our goal was to provide accessible specialist care without requiring patients to travel into the city,' said Dr Neo Bijuan, Clinical Director at Neo Smiles Dental Studio. 'Ten years on, we remain focused on bringing structured, reliable care to neighbourhoods where it's needed most.' Adapting to Challenges and Expanding Access The clinic's 10-year journey has included significant challenges, such as staffing disruptions especially during the COVID-19 pandemic. In 2023, Neo Smiles relocated its Kovan branch to Serangoon Central due to an unexpected site closure. The move enabled the team to continue operations in a more centrally located space, allowing for greater accessibility for patients in the area. Dental technology has progressed significantly, and Neo Smiles has incorporated digital tools into its clinical workflow. Intraoral scanners are used to generate precise 3D digital models of a patient's teeth and gums, replacing traditional physical impressions. The clinic also employs CBCT (Cone Beam Computed Tomography) imaging, which supports detailed diagnostics and treatment planning while using lower radiation levels compared to conventional CT scans. Patient-Centred Milestones Over the past decade, the clinic's photo wall has become a familiar feature, displaying Polaroid snapshots of patients who have completed their braces or Invisalign dental treatments. This visual record reflects the number of individuals who have completed their treatment plans and has become a long-standing tradition at Neo Smiles, capturing meaningful moments in their orthodontic care journeys. The clinic continues to serve families, with parents bringing in children for early consultations and routine follow-ups. In addition to services such as braces for kids, Neo Smiles now offers a broader range of pre- and post-treatment options, including teeth whitening, stain removal, and black triangle management. The clinic also provides procedural support such as CBCT 3D X-ray imaging and sedation options for wisdom tooth surgeries, enabling continuity of care across different treatment stages. Looking Ahead to the Next Decade Neo Smiles continues to focus on improving access to specialist orthodontic care, especially for patients in the heartlands. To support affordability, the clinic provides student braces packages, flexible instalment options and dental financial assistance for eligible patients. The clinic is also Medisave-accredited and accepts Pioneer Generation, Merdeka Generation, and CHAS subsidies. In addition, the clinic participates in the Baby Bonus Scheme and accepts CDC, LifeSG, and SG60 vouchers. As the clinic enters its 11th year, Neo Smiles remains focused on its founding purpose: providing accessible, structured treatment while prioritising the patient experience. Although its services and technology have expanded over the years, the team's focus on attentive service and fostering a welcoming environment continues to shape its daily practice. or contact the clinic directly.
